Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Title: | Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome. |
---|---|
Authors: | Trujillo-Paolillo, Alini, Tesser-Gamba, Francine, Seixas Alves, Maria Teresa, Filho, Reynaldo Jesus Garcia, Oliveira, Renato, Petrilli, Antonio Sergio, Toledo, Silvia Regina Caminada |
Source: | International Journal of Molecular Sciences; Mar2023, Vol. 24 Issue 6, p5607, 14p |
Subject Terms: | GENE expression profiling, PHARMACOGENOMICS, GENE expression, OSTEOSARCOMA, TUMORS in children |
Abstract: | Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents. In recent decades, OS treatment has reached a plateau and drug resistance is still a major challenge. Therefore, the present study aimed to analyze the expression of the genes related to pharmacogenetics in OS. The expression of 32 target genes in 80 paired specimens (pre-chemotherapeutic primary tumor, post-chemotherapeutic primary tumor and pulmonary metastasis) obtained from 33 patients diagnosed with OS were analyzed by the real-time PCR methodology. As the calibrators (control), five normal bone specimens were used. The present study identified associations between the OS outcome and the expression of the genes TOP2A, DHFR, MTHFR, BCL2L1, CASP3, FASLG, GSTM3, SOD1, ABCC1, ABCC2, ABCC3, ABCC5, ABCC6, ABCC10, ABCC11, ABCG2, RALBP1, SLC19A1, SLC22A1, ERCC1 and MSH2. In addition, the expression of the ABCC10, GGH, GSTM3 and SLC22A1 genes were associated with the disease event, and the metastasis specimens showed a high expression profile of ABCC1, ABCC3 and ABCC4 genes and a low expression of SLC22A1 and ABCC10 genes, which is possibly an important factor for resistance in OS metastasis. Therefore, our findings may, in the future, contribute to clinical management as prognostic factors as well as possible therapeutic targets. [ABSTRACT FROM AUTHOR] |
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
Database: | Complementary Index |
Full text is not displayed to guests. | Login for full access. |
FullText | Links: – Type: pdflink Text: Availability: 1 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edb&genre=article&issn=16616596&ISBN=&volume=24&issue=6&date=20230315&spage=5607&pages=5607-5620&title=International Journal of Molecular Sciences&atitle=Pharmacogenetics%20of%20the%20Primary%20and%20Metastatic%20Osteosarcoma%3A%20Gene%20Expression%20Profile%20Associated%20with%20Outcome.&aulast=Trujillo-Paolillo%2C%20Alini&id=DOI:10.3390/ijms24065607 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edb DbLabel: Complementary Index An: 162813248 RelevancyScore: 965 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 965.414672851563 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Trujillo-Paolillo%2C+Alini%22">Trujillo-Paolillo, Alini</searchLink><br /><searchLink fieldCode="AR" term="%22Tesser-Gamba%2C+Francine%22">Tesser-Gamba, Francine</searchLink><br /><searchLink fieldCode="AR" term="%22Seixas+Alves%2C+Maria+Teresa%22">Seixas Alves, Maria Teresa</searchLink><br /><searchLink fieldCode="AR" term="%22Filho%2C+Reynaldo+Jesus+Garcia%22">Filho, Reynaldo Jesus Garcia</searchLink><br /><searchLink fieldCode="AR" term="%22Oliveira%2C+Renato%22">Oliveira, Renato</searchLink><br /><searchLink fieldCode="AR" term="%22Petrilli%2C+Antonio+Sergio%22">Petrilli, Antonio Sergio</searchLink><br /><searchLink fieldCode="AR" term="%22Toledo%2C+Silvia+Regina+Caminada%22">Toledo, Silvia Regina Caminada</searchLink> – Name: TitleSource Label: Source Group: Src Data: International Journal of Molecular Sciences; Mar2023, Vol. 24 Issue 6, p5607, 14p – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22GENE+expression+profiling%22">GENE expression profiling</searchLink><br /><searchLink fieldCode="DE" term="%22PHARMACOGENOMICS%22">PHARMACOGENOMICS</searchLink><br /><searchLink fieldCode="DE" term="%22GENE+expression%22">GENE expression</searchLink><br /><searchLink fieldCode="DE" term="%22OSTEOSARCOMA%22">OSTEOSARCOMA</searchLink><br /><searchLink fieldCode="DE" term="%22TUMORS+in+children%22">TUMORS in children</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents. In recent decades, OS treatment has reached a plateau and drug resistance is still a major challenge. Therefore, the present study aimed to analyze the expression of the genes related to pharmacogenetics in OS. The expression of 32 target genes in 80 paired specimens (pre-chemotherapeutic primary tumor, post-chemotherapeutic primary tumor and pulmonary metastasis) obtained from 33 patients diagnosed with OS were analyzed by the real-time PCR methodology. As the calibrators (control), five normal bone specimens were used. The present study identified associations between the OS outcome and the expression of the genes TOP2A, DHFR, MTHFR, BCL2L1, CASP3, FASLG, GSTM3, SOD1, ABCC1, ABCC2, ABCC3, ABCC5, ABCC6, ABCC10, ABCC11, ABCG2, RALBP1, SLC19A1, SLC22A1, ERCC1 and MSH2. In addition, the expression of the ABCC10, GGH, GSTM3 and SLC22A1 genes were associated with the disease event, and the metastasis specimens showed a high expression profile of ABCC1, ABCC3 and ABCC4 genes and a low expression of SLC22A1 and ABCC10 genes, which is possibly an important factor for resistance in OS metastasis. Therefore, our findings may, in the future, contribute to clinical management as prognostic factors as well as possible therapeutic targets. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Group: Ab Data: <i>Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=162813248 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ijms24065607 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 5607 Subjects: – SubjectFull: GENE expression profiling Type: general – SubjectFull: PHARMACOGENOMICS Type: general – SubjectFull: GENE expression Type: general – SubjectFull: OSTEOSARCOMA Type: general – SubjectFull: TUMORS in children Type: general Titles: – TitleFull: Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Trujillo-Paolillo, Alini – PersonEntity: Name: NameFull: Tesser-Gamba, Francine – PersonEntity: Name: NameFull: Seixas Alves, Maria Teresa – PersonEntity: Name: NameFull: Filho, Reynaldo Jesus Garcia – PersonEntity: Name: NameFull: Oliveira, Renato – PersonEntity: Name: NameFull: Petrilli, Antonio Sergio – PersonEntity: Name: NameFull: Toledo, Silvia Regina Caminada IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: Mar2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 16616596 Numbering: – Type: volume Value: 24 – Type: issue Value: 6 Titles: – TitleFull: International Journal of Molecular Sciences Type: main |
ResultId | 1 |